Skip to content
AnalystLens

AFL · AFLAC INC

251 filings

8-K

AFL 8-K Current Reports

AFLAC INC - 251 current reports

Filing record · 2016–202610-K1110-Q328-K114

AFL filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 114 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Oct ’17Oct ’17
  2. Leadership change8-K · Nov ’19Nov ’19
  3. Leadership change8-K · Feb ’23Feb ’23
  4. FY2024 annual report10-K · Feb ’25Feb ’25
Showing 1-50 of 251 filings
8-K
Earnings & ResultsRegulation FDExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Aug 6, 2026)

Aflac reported second-quarter 2026 results that were mixed beneath a headline earnings rebound. GAAP net earnings rose 37.7% to $825 million ($1.63 per diluted share) from $599 million, but this was driven largely by a smaller net investment loss ($153 million vs. $421 million a year ago), not by stronger operations. Adjusted earnings, the company's core measure, fell 7.7% to $883 million, and adjusted EPS declined 1.7% to $1.75. Excluding a 9.3% weaker yen, which cost roughly $0.05 per share, adjusted EPS would have risen 1.1% to $1.80. Total revenues fell 1.0% to $4.1 billion, and net earned premiums dropped 6.3% as yen weakness and a reinsurance transaction at Aflac Japan offset growth in the U.S. Aflac Japan's pretax adjusted earnings rose 3.4% in yen terms, helped by a 250 basis point improvement in the benefit ratio to 64.0% and a pretax margin of 34.3%, but dollar-reported pretax earnings fell 6.2%. Aflac U.S. was weaker, with pretax adjusted earnings down 4.6% and its margin contracting 160 basis points to 20.9% on higher benefit claims. Management pointed to a $26 million expense release and $46 million of reserve remeasurement gains as supporting Q2, while flagging that variable investment income ran $72 million below long-term expectations. The U.S. net earned premium growth outlook for 2026 was trimmed to just below the 3% to 6% guidance range. Capital deployment remained robust. Aflac returned $1.3 billion to shareholders in the quarter, including $983 million of buybacks and $309 million of dividends, and declared a $0.61 quarterly dividend. Adjusted ROE excluding foreign currency remeasurement held at 16.6%, adjusted leverage was 21.8%, and the Japan regulatory ESR was 226% (240% including USP). Investors should weigh the strong capital return and ROE against the year-over-year decline in core adjusted earnings, the currency drag, and the softening top-line trend.

Aug 6, 20268-K
Other Events

AFLAC INC 8-K Report, Corporate Update (Jun 30, 2026)

Aflac Incorporated disclosed in an 8-K filing that its wholly owned subsidiary, Aflac Life Insurance Japan Ltd. ("Aflac Japan"), experienced a cybersecurity incident. An unauthorized third party accessed certain Aflac Japan systems between June 15 and June 25, 2026. While the investigation is ongoing, the compromised data includes policy details, personal information, and bank account information. Aflac Japan has taken steps to contain the breach and continues to serve its policyholders, though some systems were temporarily suspended. The incident is confined to Japan, and Aflac's U.S. operations were not affected. The full impact remains unknown, but potential risks include legal, reputational, and financial consequences, as well as regulatory inquiries and litigation.

Jun 30, 20268-K
Other EventsExhibits & Filings

AFLAC INC 8-K Report, Corporate Update (May 28, 2026)

Aflac Incorporated has announced the successful completion of a significant public offering of senior notes denominated in Japanese Yen (¥). The offering comprises four tranches with varying maturities and interest rates: ¥3.1 billion in 2.117% Senior Notes due 2029, ¥41.8 billion in 2.802% Senior Notes due 2031, ¥13.1 billion in 3.123% Senior Notes due 2033, and ¥7.9 billion in 3.482% Senior Notes due 2036. The aggregate principal amount of the offering is substantial, totaling ¥65.9 billion. The proceeds from this debt issuance are earmarked for general corporate purposes, indicating a strategic move to bolster the company's financial flexibility and support ongoing operations or future initiatives. The offering was conducted under Aflac's existing shelf registration statement and involved a syndicate of underwriters led by prominent financial institutions. The notes are unsecured, ranking equally with existing and future unsecured senior indebtedness, and are governed by an indenture with standard provisions for default and redemption, including par call options on most tranches.

May 28, 20268-K
Other EventsExhibits & Filings

AFLAC INC 8-K Report, Corporate Update (May 14, 2026)

Aflac Incorporated announced on May 14, 2026, the successful issuance of $500,000,000 in aggregate principal amount of 5.150% Senior Notes due 2036. This offering was made under the company's existing shelf registration statement and a prospectus supplement dated May 11, 2026. The proceeds from this debt issuance are designated for general corporate purposes. These Senior Notes are unsecured obligations, ranking equally with other existing and future unsecured senior indebtedness of Aflac. The notes bear a fixed interest rate of 5.150% per annum, with semi-annual payments due on May 14 and November 14, commencing November 14, 2026. The company retains the option to redeem the notes under specific conditions, including a "Par Call Date" three months prior to maturity, where redemption will be at par plus accrued interest.

May 14, 20268-K
Shareholder Matters

AFLAC INC 8-K Report, Shareholder Vote Results (May 7, 2026)

Aflac Incorporated (AFL) held its Annual Meeting of Shareholders on May 4, 2026, with the results detailed in this 8-K filing. Key outcomes include the approval of all incumbent directors for re-election, the non-binding advisory vote on executive compensation, and the ratification of KPMG LLP as the company's independent auditor for fiscal year 2026. These outcomes suggest shareholder confidence in the current board and financial oversight. Notably, a shareholder proposal advocating for an independent board chairman was not approved by the shareholders. The filing also provides details on the total voting power and the voting restrictions associated with the J&A Alliance Trust, which holds a significant stake (20%) and is subject to specific voting agreements, particularly concerning change of control transactions and votes exceeding 20% of total voting rights.

May 7, 20268-K
Earnings & ResultsRegulation FDExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Apr 29, 2026)

Aflac (AFL) reported first quarter 2026 results on April 29, 2026, with a headline GAAP swing driven largely by investment gains rather than underlying operations. Total revenues rose 27.9% to $4.3 billion and net earnings were $1.0 billion ($1.98 per diluted share), versus $29 million a year earlier. That comparison is distorted by a $963 million net investment loss in Q1 2025; this quarter included $49 million of net investment gains, driven by derivative and FX gains partly offset by CECL and impairments. The more relevant measure for investors is adjusted earnings, which were $901 million, down 0.6% year over year, while adjusted EPS rose 5.4% to $1.75 on a lower share count. Excluding current-period FX, adjusted EPS grew 6.6% to $1.77. The quality of the quarter was mixed. Aflac Japan's pretax adjusted earnings rose 5.1% on a benefit ratio improvement of 290 basis points, though about 70 basis points of that came from reserve remeasurement gains and net earned premiums fell 3.8% in yen terms. U.S. pretax adjusted earnings rose 1.4%, with a 20.4% margin, and the corporate segment swung to breakeven from a $43 million gain. Reserve remeasurement gains of $82 million also helped the quarter. Capital deployment remained substantial: Aflac repurchased $1.0 billion of stock and paid $315 million in dividends. The quarterly dividend was raised 5.2% to $0.61, with the same amount declared for Q2, extending its streak of annual dividend increases. Capital and liquidity metrics were strong, with a regulatory ESR of 227% (243% including USP), a combined U.S. RBC ratio of about 560%, adjusted leverage of 21.2% (within the 20% to 25% target), and $3.4 billion of unencumbered holding-company liquidity. Adjusted ROE was 12.8%, or 16.4% excluding foreign currency remeasurement.

Apr 29, 20268-K
Earnings & ResultsRegulation FDExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Feb 4, 2026)

Aflac reported fourth-quarter 2025 net earnings of $1.4 billion, or $2.64 per diluted share, down from $1.9 billion ($3.42) a year earlier, but this decline was driven largely by net investment gains of $537 million in Q4 2025 versus $1.0 billion in Q4 2024. Adjusted earnings, the company's preferred measure of insurance operating performance, were $818 million ($1.57 per diluted share), down 5.4% in dollars but up 0.6% per share, as share count reduction offset the earnings decline. For full-year 2025, adjusted earnings per diluted share rose 3.9% to $7.49 (3.5% excluding FX), while GAAP net earnings fell 33% to $3.6 billion ($6.82 per share) because of lower net investment gains. Total revenues declined 9.3% to $17.2 billion for the year. Segment performance was mixed. Aflac Japan's pretax adjusted earnings declined 4.7% in dollars for Q4 and 1.5% for the year, with a strong 31.3% pretax margin, supported by Miraito cancer insurance sales that rose 16.0% for the year. Aflac U.S. net earned premiums grew 4.0% in Q4 and 2.9% for the year, but its Q4 pretax margin fell to 17.4% from 19.7% on higher benefits and expenses. Shareholders' equity rose 13% to $29.5 billion, driven by discount-rate-related AOCI gains, while adjusted book value excluding foreign currency remeasurement was roughly flat per share. Management reiterated a 5.2% increase in the Q1 2026 dividend to $0.61 per share, extending a 43-year streak of dividend increases, and repurchased $800 million of stock in Q4 and $3.5 billion for the year. For 2026, management guided Japan's underlying earned premiums down 1% to 2%, a benefit ratio of 60% to 63%, and a pretax margin of 33% to 36%. For U.S., it guided net earned premium growth at the lower end of 3% to 6%, a benefit ratio of 48% to 52%, an expense ratio of 36% to 39%, and a pretax margin of 17% to 20%. Investors should note that Q4 benefited from roughly $36 million of reserve remeasurement gains and that the U.S. benefit ratio rose 230 basis points year over year.

Feb 4, 20268-K
Earnings & ResultsRegulation FDExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Nov 4, 2025)

Aflac reported third-quarter 2025 net earnings of $1.6 billion, or $3.08 per diluted share, versus a net loss of $93 million a year earlier. The swing is driven mainly by net investment gains of $275 million this quarter compared with net investment losses of $1.4 billion in Q3 2024. The more important figure for investors is adjusted earnings, which rose 9.6% to $1.3 billion, and adjusted EPS, which rose 15.3% to $2.49. Adjusted EPS excludes net investment gains and losses, so it better reflects the underlying insurance business. Adjusted ROE was 19.1%, or 22.1% excluding foreign currency remeasurement. The quarter was helped by a large favorable reserve remeasurement. Management said the assumption update added about $0.76 to EPS, with reserve remeasurement gains of $580 million. Aflac Japan's pretax margin reached 52.2%, versus 44.7% a year earlier, and management attributed much of that to the actuarial unlock rather than to run-rate improvement. Underlying premium trends are softer: Japan's net earned premiums fell 4.0%, and underlying earned premiums fell 1.2%. Aflac U.S. net earned premiums grew 2.5% and its pretax margin was 21.7%, although the U.S. expense ratio rose on a one-time $21 million contract termination fee. Capital deployment remained strong. The company repurchased $1.0 billion of stock, a record for the company, and declared a fourth-quarter dividend of $0.58 per share, extending its 43-year streak of annual dividend increases. Management raised its 2025 Japan benefit ratio range to 58% to 60% and expects a Japan pretax margin of 35% to 38%, while the U.S. guidance is unchanged. Holding company liquidity was $4.5 billion, and leverage was 22.0%, within the 20% to 25% target. Investors should weigh the strong headline earnings against the reliance on favorable reserve and actuarial effects, along with the 2025 cumulative yen effect and the June 2025 network security incident.

Nov 4, 20258-K
Financial Events

AFLAC INC 8-K Report, Financial Obligation (Aug 27, 2025)

Aflac Incorporated (AFL) has announced the completion of two significant contingent funding arrangements through the issuance of Pre-Capitalized Trust Securities (P-Caps) by two separate trusts: Wynnton Funding Trust (2035 Trust) and Wynnton Funding Trust II (2055 Trust). These transactions, totaling $2 billion ($1 billion each), provide Aflac with the flexibility to issue up to $1 billion each of its 5.251% Senior Notes due 2035 and 5.991% Senior Notes due 2055, respectively, to these trusts over a ten-year and thirty-year period. The P-Caps are designed to serve as a contingent funding mechanism, with the trusts investing proceeds in U.S. Treasury securities. These arrangements are structured as private placements and are primarily for qualified institutional buyers. The company will pay annual facility fees on the unexercised portion of the funding commitment. The P-Caps and underlying senior notes have provisions for automatic or required exercise under certain default or financial deterioration scenarios for Aflac, as well as options for early redemption by the company. This strategic move enhances Aflac's financial flexibility and contingency planning by securing access to long-term capital at predetermined rates.

Aug 27, 20258-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Aug 5, 2025)

Aflac reported second-quarter 2025 U.S. GAAP net earnings of $599 million, or $1.11 per diluted share, down sharply from $1.8 billion ($3.10) a year earlier. The decline is driven by net investment losses of $421 million this quarter versus gains of $696 million in the prior-year period, mainly from $452 million of losses on certain derivatives and foreign currency activities. Excluding these items, the core metric is adjusted earnings, which fell 7.5% to $957 million, and adjusted EPS, which fell 2.7% to $1.78. Adjusted EPS excluding current-period FX was $1.73, down 5.5%, so the stronger yen contributed a $0.04 tailwind. Underlying operations were mixed. Aflac Japan's pretax adjusted earnings fell 8.6% in dollar terms and 15.0% in yen terms, with the pretax margin declining to 32.0% from 35.3%. Japan's yen net earned premiums fell 4.8%, but new annualized premium sales rose 23.2% to ¥20.7 billion, led by the Miraito cancer product. Aflac U.S. grew more steadily, with net earned premiums up 3.4%, sales up 2.7%, pretax adjusted earnings up 1.3%, and persistency at 79.2%. Adjusted ROE was 13.7% (16.4% excluding foreign currency remeasurement), and adjusted book value per share excluding foreign currency remeasurement rose 5.2% to $44.17. Capital deployment remained strong: Aflac repurchased $829 million of stock in the quarter, leaving 30.9 million shares authorized, and declared a $0.58 third-quarter dividend. Holding-company liquidity rose to $5.1 billion after a ¥150 billion debt issuance, and adjusted leverage rose to 22.5%, still within the 20–25% target. The filing also notes a June 2025 unauthorized network access incident, which is a risk factor investors should monitor.

Aug 5, 20258-K
Other Events

AFLAC INC 8-K Report, Corporate Update (Jun 20, 2025)

Aflac Incorporated has disclosed a cybersecurity incident where unauthorized access to its network was identified on June 12, 2025. The company's incident response protocols were promptly activated, and the intrusion was contained within hours without impacting business operations, ransomware, or the ability to service policyholders. While the company's core functions remain operational, a review of potentially impacted files is underway. These files may contain sensitive personal information, including claims, health, and social security numbers, belonging to customers, beneficiaries, employees, and agents within its U.S. operations. The full scope and potential financial or reputational impact of the incident are currently unknown and under investigation. Aflac anticipates notifying affected individuals and relevant regulators, and will offer free credit monitoring and identity theft protection services. The company has engaged external cybersecurity experts to assist in its response and the ongoing review.

Jun 20, 20258-K
Other EventsExhibits & Filings

AFLAC INC 8-K Report, Corporate Update (Jun 5, 2025)

On June 5, 2025, Aflac Incorporated issued ¥74.9 billion of yen-denominated senior notes in a registered public offering across four maturities (2030, 2032, 2035, and 2040), with coupons from 1.726% to 2.779%. The offering was made under a May 30, 2025 underwriting agreement, with Mizuho, Morgan Stanley MUFG, and SMBC Nikko as representatives. The notes are senior unsecured obligations that rank equally with the company's other unsecured senior debt. Proceeds are earmarked for general corporate purposes, and the filing does not break down a specific use. The 8-K also discloses a separate private placement, entered into May 29, 2025, of ¥75.1 billion of yen-denominated senior notes maturing in 2032, 2035, 2040, and 2045, with coupons from 1.990% to 3.040%. Both issuances are yen-denominated, which lets Aflac raise capital in Japan's lower-rate market, a core part of its funding strategy given its large Japanese operations. Together the two issuances total roughly ¥150 billion, or on the order of $1 billion at recent exchange rates. The filing is a routine debt-financing disclosure with no new financial results, guidance, or changes to ratings or capital returns. For investors, the key takeaways are the size and cost of the new debt, which extends the company's maturity profile out to 2045, and the continued reliance on low-cost yen funding. The filing does not report leverage ratios, interest expense impact, or how the proceeds will be deployed, so those details would need to come from Aflac's periodic reports or earnings materials.

Jun 5, 20258-K
Shareholder Matters

AFLAC INC 8-K Report, Shareholder Vote Results (May 8, 2025)

Aflac Incorporated (AFL) filed an 8-K report on May 7, 2025, detailing the outcomes of its Annual Meeting of Shareholders held on May 5, 2025. The key takeaway for investors is the overwhelming shareholder approval of all proposals presented, including the election of all 11 director nominees, a non-binding advisory vote on executive compensation, and the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year 2025. This strong endorsement suggests continued confidence in the company's leadership and governance. Furthermore, the report clarifies the voting structure and the influence of the J&A Alliance Trust, which holds 20% of the total voting power. The existing Shareholders Agreement mandates the Trust to vote proportionally with other shareholders on certain matters, ensuring that the Trust's significant stake does not unilaterally dictate outcomes on those specific issues. The high turnout and broad support across all proposals indicate a stable shareholder base and a consensus on the company's direction.

May 8, 20258-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Apr 30, 2025)

Aflac reported a sharply weaker first quarter 2025 on a U.S. GAAP basis, with net earnings of just $29 million ($0.05 per diluted share) versus $1.9 billion ($3.25) a year earlier. The drop was driven almost entirely by a $963 million net investment loss, mostly from $888 million of losses on certain derivatives and foreign currency activities, rather than by operating deterioration. Total revenues fell 37.5% to $3.4 billion for the same reason. Investors should therefore focus on the non-GAAP adjusted measures, which strip out investment gains and losses. On an adjusted basis, the quarter was steady. Adjusted earnings were $906 million ($1.66 per diluted share), down 5.7% in dollars but flat per share, as a share count reduction of about 5% offset the decline. Aflac Japan's pretax adjusted earnings fell 10.9% in dollars (8.7% in yen) to $722 million, pressured by lower net earned premiums and floating-rate investment income, though the benefit ratio improved. Aflac U.S. was resilient, with pretax adjusted earnings up 0.6% to $358 million, net earned premiums up 1.8%, and persistency at 79.3%. Management also flagged that the weaker yen reduced adjusted EPS by $0.01 and that variable investment income ran $27 million below long-term expectations. Capital deployment remained active. Aflac repurchased $900 million of stock (8.5 million shares) and declared a $0.58 quarterly dividend, continuing its streak of annual increases. Book value per share rose to $48.55 on a GAAP basis, and adjusted book value excluding foreign currency remeasurement grew 2.2% to $42.61. Adjusted ROE was 12.7% (15.6% excluding FX remeasurement). Overall, the filing shows a headline GAAP loss from non-operating items, while the core insurance franchise held up reasonably well.

Apr 30, 20258-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Feb 5, 2025)

Aflac reported solid fourth-quarter and full-year 2024 results on February 5, 2025. Q4 adjusted earnings rose 18.2% to $865 million ($1.56 per diluted share, up 24.8%), and full-year adjusted EPS grew 15.7% to $7.21 (18.6% excluding the weaker yen). GAAP net earnings were inflated by $1.0 billion of Q4 net investment gains, mainly from derivatives and FX, so GAAP EPS of $3.42 overstates underlying performance. Investors should focus on adjusted figures. Adjusted book value excluding FX remeasurement rose 3.2% to $42.46 per share, and the adjusted ROE excluding FX remeasurement was 14.5% for the quarter. Aflac Japan was the main driver, with pretax adjusted earnings up 1.0% in Q4 and a full-year pretax margin of 36.0%, the highest in about 30 years, though yen-denominated premiums fell 6.9% for the year. U.S. pretax adjusted earnings were up 9.3% in Q4 but down 5.5% for the full year, with sales declining 1.0% and the company citing a shift toward more profitable growth. Management reiterated a 16% increase in the first-quarter dividend to $0.58 per share, marking 42 consecutive years of dividend increases, and deployed $750 million in Q4 buybacks ($2.8 billion for the year). For 2025, management guided Japan's benefit ratio toward the high end of 64% to 66%, its expense ratio to the low end of 20% to 23%, and its pretax margin to the low end of 30% to 33%. For the U.S., it guided the benefit ratio to the low end of 48% to 52%, the expense ratio to the high end of 36% to 39%, and the pretax margin to the high end of 17% to 20%. These updates signal lower Japan profitability in 2025 than 2024's exceptional margin, which is an important consideration for investors.

Feb 5, 20258-K
Earnings & ResultsLeadership ChangesExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Oct 30, 2024)

Aflac reported a third-quarter 2024 GAAP net loss of $93 million, or $0.17 per diluted share, versus earnings of $1.6 billion, or $2.64 per share, a year earlier. The swing was driven by $1.4 billion of net investment losses, mainly from derivatives and foreign currency activity as the yen strengthened about 12.9% during the quarter. Total revenues fell 40.4% to $2.9 billion. Investors should focus on the underlying results. Adjusted earnings rose 10.6% to $1.2 billion, and adjusted EPS grew 17.4% to $2.16 (19.0% to $2.19 excluding the $0.03 currency impact). Aflac Japan was the main driver, with pretax adjusted earnings up 25.5% in yen terms and a pretax margin of 44.7%, helped by roughly ¥39.7 billion of remeasurement gains. The U.S. segment was weaker, with pretax adjusted earnings down 26.8% and a margin of 20.8%, reflecting lower remeasurement gains and higher claims. Balance sheet and capital metrics were mixed but stable. Adjusted book value per share was $51.21, and book value per share including unrealized FX translation losses rose 7.3% to $43.77. The annualized adjusted ROE was 16.7%, or 17.0% excluding currency impact. Aflac repurchased $500 million of stock (4.9 million shares) and declared a $0.50 quarterly dividend, extending its streak of annual dividend increases to 42 years in 2024. Adjusted leverage rose to 21.0% because of yen-driven changes in the value of yen-denominated debt, which management described as an intentional part of its hedging program. The 8-K also disclosed a leadership change. Virgil R. Miller will become President of Aflac effective January 1, 2025, while continuing as President of Aflac U.S. Daniel P. Amos will step down as President but remain Chairman and CEO. Management indicated that the U.S. net earned premium growth will likely be at the low end of its 3% to 5% guidance range, and that Japan's full-year benefit ratio will be 62% to 63%, with a 35% to 36% pretax margin.

Oct 30, 20248-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Jul 31, 2024)

Aflac reported Q2 2024 results on July 31, 2024, with net earnings of $1.8 billion ($3.10 per diluted share), up 14.4% from $2.71 a year earlier, helped by $696 million of net investment gains, largely from derivatives and FX activity. Adjusted earnings, the company's preferred underlying measure, rose 8.5% to $1.0 billion, and adjusted EPS grew 15.8% to $1.83. Excluding a $0.07 currency headwind from the weaker yen, adjusted EPS would have increased 19.6% to $1.89. Total revenues slipped 0.7% to $5.1 billion, reflecting a 6.9% decline in net earned premiums that was largely driven by Japan's prior-year reinsurance transaction and paid-up policies. Segment performance was strong. Aflac Japan's pretax adjusted earnings rose 5.1% in dollar terms (18.6% in yen), with a pretax margin of 35.3%, while Aflac U.S. grew pretax adjusted earnings 3.8% to $383 million with a 22.7% margin. U.S. sales rose 2.0% and Japan's total new sales rose 4.5% in yen, which management described as putting the Japan business back on track for the year. Shareholder returns remained robust: the company repurchased a record $800 million of stock (9.3 million shares), declared a $0.50 quarterly dividend, and reported 41 consecutive years of dividend growth. Adjusted book value per share rose 12.1% to $52.26, and adjusted ROE was 14.3% (14.8% excluding FX impact). The main watch items are the sharp decline in Japan's net earned premiums, which fell 5.7% in yen, the rise in the U.S. expense ratio tied to growth initiatives, and commercial real estate loan stress, with a $1.0 billion watchlist and $14 million of additional CECL reserves. Adjusted leverage of 19.5% sat just below management's 20-25% target corridor. Overall, the quarter reflected solid operating earnings growth, strong capital deployment, and a balanced but FX-sensitive profile.

Jul 31, 20248-K
Shareholder Matters

AFLAC INC 8-K Report, Shareholder Vote Results (May 10, 2024)

Aflac Incorporated (AFL) filed an 8-K report detailing the results of its Annual Shareholder Meeting held on May 6, 2024. The primary focus of the filing is the outcome of shareholder votes on key corporate matters. Investors will be interested to know that all three proposals put forth were overwhelmingly approved by shareholders. These included the election of ten members to the board of directors, a non-binding advisory vote on executive compensation, and the ratification of KPMG LLP as the company's independent auditor for the fiscal year ending December 31, 2024. The strong approval across all proposals indicates shareholder confidence in the current leadership and governance structure. The report also provided detailed voting breakdowns, highlighting a significant majority of votes cast in favor of each proposal. Notably, the number of broker non-votes was consistent across most director elections and advisory proposals, suggesting a high level of participation and awareness among shareholders. The filing also referenced a Shareholders Agreement concerning J&A Alliance Trust's voting power, which requires proportional voting alignment under specific circumstances, reinforcing the established governance framework.

May 10, 20248-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (May 1, 2024)

Aflac reported first-quarter 2024 net earnings of $1.9 billion, or $3.25 per diluted share, up 58.2% from $1.2 billion a year earlier. That headline figure was inflated by $951 million of net investment gains, driven mainly by $703 million of gains on derivatives and foreign currency. The more representative measure, adjusted earnings, rose only 0.8% to $961 million, while adjusted EPS grew 7.1% to $1.66 thanks to a lower share count. Excluding a $0.08 negative yen impact, adjusted EPS rose 12.3% to $1.74. Investors should weigh the adjusted figures more heavily when judging underlying growth. Underlying operations were mixed. Aflac Japan's pretax adjusted earnings rose 2.8% in dollar terms to $810 million, with a pretax margin of 32.8% versus 28.2% a year ago, helped by lower benefits and expenses. However, Japan net earned premiums fell 16.3% in dollars and new annualized sales declined 5.1%. Aflac U.S. showed modest growth, with net earned premiums up 3.3% and pretax adjusted earnings up 1.1% to $356 million, though U.S. sales fell 5.2%. The weaker yen, which averaged 148.67 per dollar (11.0% weaker), was a headwind throughout. Capital returns remained strong. Aflac repurchased a record $750 million of stock, retired 9.3 million shares, and declared a second-quarter dividend of $0.50 per share, extending a 41-year streak of dividend growth. Shareholders' equity reached $23.5 billion, or $41.27 per share, and adjusted book value per share rose 12.4% to $50.22. Adjusted ROE was 13.7%, and the company disclosed a commercial real estate watchlist of about $1.2 billion, with roughly $600 million in active foreclosure proceedings.

May 1, 20248-K
Other EventsExhibits & Filings

AFLAC INC 8-K Report, Corporate Update (Mar 21, 2024)

On March 19 and March 21, 2024, Aflac Incorporated (AFL) raised a combined ¥75.0 billion in privately placed yen-denominated senior notes and ¥48.6 billion in registered yen-denominated senior notes, totaling roughly ¥123.6 billion (about $800 million-plus at 2024 exchange rates, an approximation not stated in the filing). The filing is a debt-financing disclosure, not an earnings or operating update, so it contains no information on revenue, profitability, or guidance. The company states that proceeds from both offerings are for general corporate purposes. The private placement comprises five tranches maturing between 2034 and 2054, with coupons from 1.600% to 2.400%. The registered offering comprises three tranches maturing in 2029, 2031 and 2034, with coupons from 1.048% to 1.682%. All notes are senior unsecured obligations that rank equally with Aflac's other unsecured senior debt, and both sets are subject to customary covenants and events of default. The registered notes are also redeemable at par plus accrued interest starting three months (2029 and 2031 notes) or six months (2034 notes) before maturity. For investors, the key takeaways are that Aflac is diversifying its funding base into the yen market and extending its debt maturity profile out to 2054, while locking in comparatively low coupons relative to U.S. dollar debt. The new debt increases Aflac's leverage and interest obligations, which investors should weigh against the company's ability to service them, but the filing provides no balance sheet data to quantify the impact.

Mar 21, 20248-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Jan 31, 2024)

Aflac reported Q4 2023 net earnings of $268 million ($0.46 per diluted share), down sharply from prior-year results on a per-share basis, but this decline was driven largely by investment losses and a one-time reinsurance novation charge. Adjusted earnings, the company's preferred operating measure, fell 10.4% to $732 million ($1.25 per diluted share, down 4.6%). Net investment losses of $511 million were driven mainly by derivative and FX losses of $580 million tied to yen movements, and a $151 million pretax loss on a reinsurance treaty novation weighed on Corporate and Other. Full-year 2023 adjusted EPS rose 9.9% to $6.23 (13.4% excluding a $0.19 currency drag), and full-year net earnings were $4.7 billion ($7.78 per diluted share). Segment performance was mixed. Aflac Japan's pretax adjusted earnings grew 9.7% in yen terms, with the pretax margin expanding to 30.4% from 26.7%, though net earned premiums fell 8.5% on paid-up policies and reinsurance transactions. Aflac U.S. showed stronger top-line momentum, with net earned premiums up 1.1% and quarterly sales up 2.6%, but its pretax adjusted earnings fell 10.9% as expenses rose and its expense ratio climbed to 43.4%. Management reiterated a 19% increase in the first-quarter 2024 dividend to $0.50 per share, extending 41 consecutive years of dividend increases, and repurchased $700 million of stock in the quarter ($2.8 billion for the full year). For 2024, management guided Aflac Japan toward a 66-68% benefit ratio, a 19-21% expense ratio, and a 29-31% pretax profit ratio, with underlying Japan net earned premiums expected to decline 1.5% to 2.5%. For Aflac U.S., guidance calls for net earned premiums growth of 3% to 5%, a benefit ratio of 45-47%, and a pretax profit ratio of 19-21%. Key watch items include the sustainability of remeasurement gains that flattered recent benefit ratios, the commercial real estate watchlist (about $1.2 billion, with roughly $500 million in active foreclosure), leverage of 19.7% just below the 20-25% corridor, and yen/dollar sensitivity.

Jan 31, 20248-K
Leadership Changes

AFLAC INC 8-K Report, Executive Changes (Dec 8, 2023)

Aflac Incorporated announced a key leadership transition within its finance department. June P. Howard, Senior Vice President and Chief Accounting Officer, will retire effective December 31, 2023. This marks the end of Ms. Howard's tenure, and the company has moved swiftly to appoint a successor. Robin Blackmon has been named the new Senior Vice President and Chief Accounting Officer, effective January 1, 2024. Ms. Blackmon brings extensive experience within Aflac, having most recently served as Vice President and Deputy Chief Accounting Officer. Her appointment reflects a focus on internal talent and continuity in financial leadership, with a compensation package designed to align with her new responsibilities, including a base salary, annual bonus, and performance-based equity award.

Dec 8, 20238-K
Leadership ChangesCorporate Changes

AFLAC INC 8-K Report, Executive Changes (Nov 17, 2023)

Aflac Incorporated (AFL) has filed an 8-K report detailing a significant leadership transition and an amendment to its bylaws. Effective January 1, 2024, Daniel P. Amos, currently Chairman and CEO, will also assume the role of President. This appointment consolidates top leadership positions under Mr. Amos, who has a long-standing history with the company. Investors should note that his extensive background and compensation details are available in the company's 2023 proxy statement. Additionally, the company's Board of Directors amended and restated its bylaws, notably removing the 'Article IX Emeritus Directors' provision. While the specific implications of this bylaw change require further review of the full document, it suggests a streamlining or modification of past governance structures. Investors focused on corporate governance should consult the newly amended bylaws, filed as an exhibit with this report.

Nov 17, 20238-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Nov 1, 2023)

Aflac's third-quarter 2023 results showed strong underlying earnings momentum, with adjusted earnings per diluted share up 27.8% to $1.84 and adjusted earnings up 20.3% to $1.1 billion. Reported net earnings fell 11.9% to $1.6 billion ($2.64 per diluted share) versus $1.8 billion a year earlier, but that decline largely reflects the prior-year quarter's $695 million deferred tax release and the timing of net investment gains (here $423 million, primarily from derivatives and currency activity). Total revenues rose 5.2% to $4.95 billion, and the adjusted return on equity excluding foreign currency impact was 16.1%. Management attributed much of the earnings strength to lower benefits, including actuarial assumption unlocks that produced roughly $205 million of remeasurement gains, which flatter the quarter and may not recur at the same level. Segment performance was mixed. Aflac U.S. pretax adjusted earnings rose 38.6% to $478 million with a 28.8% pretax margin, helped by reserve remeasurement gains, while absorbing a software write-off and elevated growth-initiative expenses. Aflac Japan pretax adjusted earnings rose 6.4% in dollar terms (11.4% in yen), but yen-denominated net earned premiums fell 2.8%, and the segment's sales growth was driven largely by the new cancer product. The weaker yen reduced adjusted EPS by $0.06 in the quarter and cut nine-month adjusted EPS growth by about 0.17 per share. Capital and shareholder returns remained strong: the company repurchased $700 million of stock, the Board raised the first-quarter 2024 dividend 19% to $0.50 per share, and holding company liquidity stood at $3.3 billion. Commercial real estate exposure (a roughly $1.0 billion watchlist) and the yen-driven swings in book value and leverage are the main areas for investors to monitor.

Nov 1, 20238-K
Leadership Changes

AFLAC INC 8-K Report, Executive Changes (Nov 1, 2023)

Aflac Incorporated (AFL) has announced a significant leadership transition involving Frederick J. Crawford, its President and Chief Operating Officer. Mr. Crawford is set to retire from his employee role on September 30, 2024. His current role as President and COO will conclude on December 31, 2023, after which he will transition to an Executive Vice President position until his retirement. This transition outlines Mr. Crawford's compensation and benefits through his retirement. Key terms include a continued base salary of $997,500 annually until his retirement, continued vesting of previously granted performance-based restricted stock based on company performance, and full vesting of his Executive Deferred Compensation Plan upon retirement. He will also receive a lump sum payment for COBRA continuation coverage. This announcement provides clarity on leadership succession and executive compensation arrangements.

Nov 1, 20238-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Aug 1, 2023)

Aflac reported second-quarter 2023 net earnings of $1.6 billion, or $2.71 per diluted share, up 24.9% from $2.17 a year ago, while adjusted earnings rose a more modest 1.0% in dollars to $954 million. Adjusted earnings per diluted share increased 7.5% to $1.58, held back by a $0.04 negative currency impact. The gap between GAAP and adjusted results was driven by $555 million of net investment gains, largely from derivative and foreign currency activity tied to the weaker yen, which the company excludes from its adjusted measures. Investors should therefore focus on the adjusted figures, where underlying growth was modest. Segment performance was mixed. Aflac Japan's pretax adjusted earnings fell 5.8% in dollars to $822 million, and net earned premiums declined 11.6% in dollars, reflecting limited-pay products reaching paid-up status and a Q1 reinsurance transaction. Aflac U.S. was the bright spot, with pretax adjusted earnings up 7.6% to $369 million, net earned premiums up 2.2%, and a pretax margin of 22.2%. Management noted that Q2 U.S. benefit ratios were unusually low, with roughly 210 basis points of benefit from reserve remeasurement gains, so that tailwind may not persist. Japan's pretax margin rose to 30.4% on favorable claims experience, which also included remeasurement gains. Capital deployment remained active. The company repurchased $700 million of stock (10.5 million shares) in the quarter, leaving 95.8 million shares authorized, and declared a $0.42 third-quarter dividend. Adjusted book value per share rose 11.5% to $46.61, and the adjusted ROE was 13.9%, or 14.3% excluding foreign currency. Leverage of 19.4% sits just below management's 20%–25% corridor, a level the CFO attributed mainly to yen weakness rather than debt changes. Management expects the third-quarter annual assumption review under the new LDTI accounting regime to produce further remeasurement gains or losses.

Aug 1, 20238-K
Leadership ChangesExhibits & Filings

AFLAC INC 8-K Report, Executive Changes (Jun 13, 2023)

Aflac Incorporated (AFL) announced on June 9, 2023, through its Compensation Committee, that it is freezing benefit accruals under two key executive retirement plans: the Supplemental Executive Retirement Plan (SERP) and the American Family Corporation Retirement Plan for Senior Officers (SORP). This freeze will be effective as of December 31, 2023. While all retirement benefit accruals will cease, active participants in the SERP may continue to accrue service towards early or delayed early retirement eligibility, based on their final average earnings as of the freeze date. Accruals related to office use and medical benefits under the SORP will also continue. In conjunction with the freeze, impacted executives will become eligible for "Executive Employer Contributions" under the Aflac Incorporated Executive Deferred Compensation Plan. The specific contribution rates will be determined by the Compensation Committee based on post-freeze compensation. This move signals a shift in how the company provides retirement benefits to its senior executives, moving away from defined benefit structures towards a more deferred compensation model for benefits earned after the freeze date.

Jun 13, 20238-K
Shareholder Matters

AFLAC INC 8-K Report, Shareholder Vote Results (May 4, 2023)

This 8-K filing from Aflac Incorporated (AFL) details the outcomes of its Annual Meeting of Shareholders held on May 1, 2023. The key takeaway for investors is the strong shareholder support for the company's board of directors, executive compensation practices, and the ratification of its independent auditor. All proposals put forth, including the election of eleven board members, the advisory vote on executive compensation, and the ratification of KPMG LLP as the independent registered public accounting firm, received overwhelming approval. Furthermore, shareholders voted to hold the "say-on-pay" advisory vote annually, indicating a preference for regular shareholder input on executive compensation. The significant majority of votes in favor across all proposals, coupled with a substantial number of broker non-votes in some instances, suggests broad alignment between management and its shareholders on key governance and financial oversight matters.

May 4, 20238-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Apr 27, 2023)

Aflac Incorporated (NYSE: AFL) reported first quarter 2023 results on April 26, 2023, with net earnings of $1.2 billion ($1.94 per diluted share), up 13.5% in dollar terms and 21.3% per share versus the prior year. Adjusted earnings were $953 million ($1.55 per diluted share), up 1.2% in dollars and 7.6% per share. The per-share figure was helped by a lower share count after $700 million of buybacks (10.3 million shares repurchased). Excluding a $0.07 currency headwind from the weaker yen, adjusted EPS would have risen 12.5% to $1.62. Total revenues fell 7.2% to $4.8 billion, largely due to the weaker yen and the impact of the new long-duration insurance accounting standard (LDTI) adopted January 1, 2023. The quarter's profitability was supported by low benefit ratios in both segments, with Japan's pretax margin rising to 28.2% and the U.S. margin to 21.2%. Management noted that remeasurement gains of roughly $53 million under LDTI helped results, and that variable investment income ran $39 million (about $0.05 per share) below long-term expectations. Aflac Japan's pretax adjusted earnings fell 9.4% in dollar terms but rose 3.2% in yen terms. Japan's sales rose 10.8% in yen, driven by the rollout of its new cancer product, and U.S. sales increased 5.3%. Persistency was a watch item in both markets: 93.9% in Japan (down 40 basis points) and 77.9% in the U.S. (down about 80 basis points). Capital and balance-sheet metrics remained solid. Adjusted ROE was 14.2% (14.8% excluding currency impact), shareholders' equity was $19.8 billion ($32.65 per share), and adjusted book value per share was $44.66. Leverage stood at 20.5%, toward the lower end of management's 20%–25% target corridor. The board declared a $0.42 quarterly dividend, payable June 1, 2023, extending a streak of dividend increases that reached 40 consecutive years in 2022. Management described its posture as defensive, citing evolving economic conditions. Total investments and cash fell to $120.5 billion from $132.6 billion a year earlier, mainly because of the weaker yen and higher interest rates.

Apr 27, 20238-K
Regulation FDExhibits & Filings

AFLAC INC 8-K Report, Regulation FD Disclosure (Feb 27, 2023)

Aflac's February 27, 2023 8-K furnishes an updated Q4 2022 Financial Analysts Briefing (FAB) Supplement, recast for the January 1, 2023 adoption of LDTI (ASU 2018-12 as amended). The company voluntarily restated 2021 and 2022 comparative data for presentation purposes only, with a January 1, 2021 transition date. Its most consequential accounting change for the P&L is that the change in the deferred profit liability on limited-payment products moves from benefits and claims to net earned premiums; this reclassification has no effect on net earnings. Investors should read the supplement as a reset of the comparative baseline rather than a change in reported profitability. On a full-year basis, 2022 U.S. GAAP net earnings rose 4.4% to $4,418 million ($6.93 per diluted share, up 10.9%), while adjusted earnings fell 7.9% to $3,614 million ($5.67 per diluted share, down 2.2%). Adjusted EPS excluding current-period foreign currency impact was $6.08, up 4.8%, which highlights the yen weakness that depressed reported results. Net earned premiums fell 12.8% to $14,901 million, and the company's total adjusted revenues declined as well. Aflac Japan pretax adjusted earnings fell 12.6% in dollar terms (down 19.7% in Q4) largely because of yen depreciation, though yen-denominated pretax adjusted earnings rose 4.6%. Aflac U.S. pretax adjusted earnings were roughly flat at $1,359 million, with the U.S. combined ratio improving to 79.0%. Balance sheet metrics show a sharp mark-to-market effect: total shareholders' equity rose to $20,140 million from $17,031 million, while AOCI was a large negative driven by fixed-income unrealized losses and the discount-rate effect. Adjusted book value per share ex-AOCI was $43.18 at year-end 2022 (up 10.7%), and adjusted book value including foreign currency translation was $37.39 (up 3.9%). Adjusted ROE was 13.9%, versus 15.8% in 2021, and the adjusted debt-to-capitalization ratio was 23.4%. Note that the supplement is described as unaudited statistical data and that the company's guidance and risk factors are in its separate filings.

Feb 27, 20238-K
Leadership Changes

AFLAC INC 8-K Report, Executive Changes (Feb 10, 2023)

Aflac Incorporated (AFL) has filed a Form 8-K to announce the approval of its 2023 Management Incentive Plan (2023 MIP) by the Compensation Committee of its Board of Directors on February 9, 2023. This plan outlines the framework for awarding bonuses to officers and other employees based on the achievement of specific performance goals. The Compensation Committee retains broad discretion in administering the plan, including selecting participants, granting awards, determining performance periods and goals, and certifying attainment. This action reflects the company's continued focus on aligning executive and employee compensation with company performance.

Feb 10, 20238-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Feb 1, 2023)

Aflac's Q4 2022 results were dominated by a sharp foreign-exchange drag: reported net earnings fell 82.2% to $185 million ($0.30 per diluted share) as the weaker yen produced $521 million of net investment losses, mostly from derivatives and currency activity. Underlying performance was steadier. Adjusted earnings declined 5.2% to $806 million, and adjusted EPS rose 0.8% to $1.29. Excluding an $0.11 FX headwind, adjusted EPS would have been $1.40, up 9.4%. Full-year 2022 adjusted EPS was $5.33, down 10.3% (or down 4.5% excluding the $0.34 FX impact), and reported net earnings were $4.2 billion ($6.59 per diluted share), boosted by a $452 million deferred tax release. Segment trends were mixed. Aflac Japan's pretax adjusted earnings fell 20.6% in dollar terms to $704 million, though the pretax margin improved to 25.5%. Japan's new annualized sales rose 11.4% in the quarter on a new cancer product, but full-year sales were flat, and the weak yen cut dollar-reported premiums sharply. Aflac U.S. was the bright spot: pretax adjusted earnings rose 30.3% to $340 million, helped by unusually low benefit ratios and IBNR releases, while U.S. sales grew 17.4% in the quarter and 16.1% for the year. Management flagged that these low benefit ratios are not expected to persist and that U.S. persistency fell to 77.0%. Capital and shareholder returns remained robust. Management reaffirmed a 5.0% increase in the quarterly dividend to $0.42 per share, extending a 40-year streak of annual dividend increases. Aflac repurchased $600 million of stock in Q4 and $2.4 billion for the full year, with $116.6 million shares remaining under authorization. Leverage was 20.8%, toward the low end of its 20%-25% corridor, and holding company liquidity was $3.1 billion. Adjusted book value per share rose 9.7% to $43.51, though reported book value per share fell 28.7% to $36.35 because of AOCI losses tied to the yen and rising rates.

Feb 1, 20238-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Oct 31, 2022)

Aflac's third quarter 2022 results were headlined by GAAP net earnings of $1.6 billion, or $2.53 per diluted share, but this figure was inflated by a one-time $695 million release of deferred taxes. The more representative measure, adjusted earnings, fell 29.7% year over year to $725 million, and adjusted EPS declined 24.8% to $1.15. Management attributed the drop to a sharp spike in COVID-related claims in Japan (the Japan benefit ratio rose 940 basis points, which the CFO estimated at a $0.29 per share hit), a $0.11 per share shortfall in alternative investment returns, and a weaker yen that reduced EPS by $0.08. A $70 million make-whole call gain partially offset these headwinds. The segment picture was mixed. Aflac Japan's pretax adjusted earnings fell 19.2% in yen terms, and its pretax margin compressed to 21.6% from 26.3%, though management expects the benefit ratio to normalize in the fourth quarter after the scope of 'deemed hospitalization' was narrowed on September 26. Aflac U.S. showed weaker persistency (77.6% on a rolling basis, down 230 basis points), higher expense ratios tied to growth investments, and a 13.7% decline in pretax adjusted earnings, although U.S. sales rose 11.8%. Japan sales increased 10.2% on a new cancer product launch. Capital management remained active. Aflac repurchased $650 million of stock (11.1 million shares) and declared a $0.40 quarterly dividend, marking 40 consecutive years of dividend increases. Leverage fell to 19.5%, slightly below the company's 20-25% target corridor, partly because weaker yen reduced the dollar value of yen-denominated debt. Adjusted book value per share including FX translation rose 2.2% to $37.20, and adjusted ROE was 10.6% (11.4% excluding FX). The company also completed a liability management transaction raising ¥180 billion in yen debt at a weighted average coupon of 89 basis points, which management estimates will reduce run-rate interest expense by about $32 million.

Oct 31, 20228-K
Leadership Changes

AFLAC INC 8-K Report, Executive Changes (Oct 25, 2022)

Aflac Incorporated (AFL) filed an 8-K on October 25, 2022, primarily detailing changes in executive compensation and employment terms. The report announces a retirement and transition plan for Eric M. Kirsch, Executive Vice President, Global Chief Investment Officer, and President of Aflac Global Investments. Mr. Kirsch will retire from employment on March 31, 2023, but will continue in his Chief Investment Officer role until December 31, 2022, and then transition to an Executive Vice President role until his retirement. He will also enter into a one-year consulting agreement post-retirement, receiving a substantial annual fee for transition advisory services. Additionally, the company amended the employment agreements for key executives, including Fred Crawford (President and COO), Max Broden (CFO), and Audrey Boone Tillman (General Counsel). These amendments modify the definition of "Good Reason" for termination, notably limiting the grounds upon which an executive can claim "Good Reason" outside of a change in control scenario. Specifically, the removal of "diminution of duties," "assignment of significantly inconsistent duties," and "material breach by the Company" from the "Good Reason" definition suggests a strengthening of the company's position in executive employment contracts.

Oct 25, 20228-K
Other EventsExhibits & Filings

AFLAC INC 8-K Report, Corporate Update (Sep 14, 2022)

Aflac Incorporated (AFL) announced on September 14, 2022, the issuance of ¥93 billion in aggregate principal amount of senior notes across four tranches with varying maturity dates and interest rates, ranging from 1.075% due 2029 to 2.144% due 2052. This debt offering was conducted through a public offering under the company's existing registration statement. The primary purpose of this issuance is to refinance existing debt, specifically targeting the redemption of Aflac's 3.625% Senior Notes due 2024 and 3.25% Senior Notes due 2025. The company intends to use the net proceeds from the new note issuance, along with available cash and borrowings from its senior term loan facility, to cover the redemption costs. Any excess proceeds will be allocated for general corporate purposes. The Notes are unsecured and rank equally with existing and future senior unsecured indebtedness.

Sep 14, 20228-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Aug 1, 2022)

Aflac's Q2 2022 results (filed August 1, 2022) show a mixed picture: GAAP net earnings rose 25.6% to $1.4 billion ($2.16 per diluted share), but this was driven by $564 million of net investment gains, largely from yen-related derivative and FX gains. Underlying profitability weakened. Adjusted earnings fell 13.1% to $939 million, and adjusted EPS declined 8.2% to $1.46. Adjusted earnings excluding the current-period FX impact were down 7.8%, with a $0.09 per-share drag from the weaker yen (average yen/dollar rate 129.39, 15.4% weaker year over year). Total revenues fell 2.9% to $5.4 billion, and net earned premiums dropped 13.3% in the quarter, reflecting Japan's shrinking premium base and the yen's translation effect. Segment performance was uneven. Aflac Japan's pretax adjusted earnings fell 14.3% in dollar terms to $860 million, though they rose 1.6% in yen terms, supported by reserve releases and higher investment income. Japan's sales declined 6.4% in yen terms, and persistency held at 94.3%. Aflac U.S. pretax adjusted earnings dropped 15.5% to $349 million, with the margin compressing to 21.4% from 25.4%. The decline reflected higher expenses tied to growth investments, including dental, vision, and group benefits, and persistency fell 220 basis points to 77.9%. U.S. sales grew 15.6% to $305 million, which is a positive signal for the growth strategy. Capital management remained a focus. Aflac repurchased $650 million of stock (11.2 million shares) and declared a $0.40 quarterly dividend, its 39th year of dividend growth. Shareholders' equity fell to $26.4 billion because of a $3.3 billion FX translation loss. Adjusted book value per share rose 10.9% to $42.45, and adjusted ROE was 14.1% (14.9% excluding FX). Leverage was 20.6%, near the low end of management's 20%-25% corridor. Holding company liquidity was $4.0 billion. For investors, the key question is whether the strong GAAP headline reflects durable earnings power or a currency-driven one-time gain. Adjusted metrics point to meaningful pressure from the weak yen and rising expenses.

Aug 1, 20228-K
Shareholder Matters

AFLAC INC 8-K Report, Shareholder Vote Results (May 4, 2022)

Aflac Incorporated filed an 8-K report detailing the results of its Annual Meeting of Shareholders held on May 2, 2022. The primary focus of the filing is the voting outcomes on key corporate governance and operational matters. Shareholders overwhelmingly approved the election of all 11 director nominees, the advisory proposal on executive compensation (also known as 'Say-on-Pay'), and the ratification of KPMG LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2022. These approvals indicate strong shareholder confidence in the current board of directors, the company's executive compensation strategy, and its external audit oversight. The significant 'For' votes across all proposals, coupled with relatively low numbers of abstentions and broker non-votes (except for the director elections where a substantial number of shares were not voted by brokers, impacting the raw vote count but not the outcome), suggest a stable governance environment for Aflac. Investors can interpret these results as a positive signal regarding the company's leadership and financial reporting integrity.

May 4, 20228-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Apr 27, 2022)

Aflac's first quarter 2022 results showed net earnings of $1.0 billion, or $1.58 per diluted share, down from $1.87 a year earlier, as net investment gains of $122 million ($0.19 per share) partially offset weaker underlying performance. Adjusted earnings, the company's preferred measure of insurance operations, fell 12.4% to $927 million, and adjusted EPS declined 7.2% to $1.42. Management attributed the decline largely to a $0.06 per share headwind from the weaker yen (average 116.18 per dollar, 8.9% weaker year over year) and to a tough comparison with a first quarter 2021 that benefited from unusually low pandemic-related claims and strong variable investment income. Segment trends were mixed. Aflac Japan's pretax adjusted earnings fell 2.8% in dollar terms (up 6.8% in yen), supported by a 25.3% pretax margin, but sales declined 14.8% and net earned premiums dropped 4.3% in yen terms as paid-up policies and pandemic-constrained face-to-face selling weighed on growth. Aflac U.S. showed the sharpest earnings decline, with pretax adjusted earnings down 27.0% to $325 million and the margin compressing to 19.8%, driven by higher expense ratio from lapsation-related DAC amortization and growth-platform build-out costs; on the positive side, U.S. sales rose 19.0% to $299 million. Balance sheet metrics remained solid, with adjusted book value per share up 10.1% to $40.93, a 14.7% annualized adjusted ROE excluding FX impact, and leverage of 21.7%, though total investments and cash declined 7.5% year over year. Capital deployment continued, with $500 million used to repurchase 8.0 million shares and a second quarter dividend of $0.40 per share declared, up 21.2% from the prior year's level and marking the company's 39th consecutive year of dividend increases. Management's outlook expects stronger Japan sales in the second half of 2022 if pandemic conditions ease, and it highlighted a rough sensitivity of about $0.06 to $0.08 of annualized adjusted EPS for every 5-yen move against the dollar.

Apr 27, 20228-K
Leadership ChangesCorporate ChangesExhibits & Filings

AFLAC INC 8-K Report, Executive Changes (Feb 11, 2022)

Aflac Incorporated (AFL) filed an 8-K on February 11, 2022, detailing amendments to its executive compensation and corporate governance practices. The company updated its restricted stock award agreements for U.S. and Japan participants to clarify the treatment of equity awards when performance vesting goals are not met. Notably, the definition of "Retirement" under the U.S. agreement was modified to include a more accessible pathway (age 55 with 10 years of service, versus 15 years previously) for voluntary termination of employment. Furthermore, Aflac amended and restated its bylaws, removing age limitations for Board members and clarifying the roles of the Chairman and the Executive Committee. These changes aim to enhance flexibility in board composition and executive appointments, aligning with modern corporate governance standards. The amendments to the stock award agreements will also apply retroactively to certain outstanding performance-based restricted stock grants made in February 2021 to key executives.

Feb 11, 20228-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Feb 2, 2022)

Aflac reported fourth-quarter 2021 net earnings of $1.0 billion, or $1.57 per diluted share, up from $951 million ($1.35) a year earlier, while total revenues fell 8.1% to $5.4 billion. Adjusted earnings, the company's preferred measure of underlying insurance performance, rose 12.6% to $850 million, and adjusted EPS increased 19.6% to $1.28. Growth was supported by lower benefit ratios tied to pandemic-related claim trends and above-expectation returns from alternative investments ($0.13 per share above return expectations in the quarter). Aflac Japan's pretax adjusted earnings rose 17.9% in yen terms, while Aflac U.S. pretax adjusted earnings jumped 39.6% on lower incurred benefits, even as net earned premiums declined in both segments. Full-year 2021 results were more mixed on the top line: total revenues were roughly flat at $22.1 billion, and GAAP net earnings fell 9.5% to $4.3 billion ($6.39 per diluted share), though adjusted EPS rose 19.8% to $5.94 ($6.00 excluding currency). Sales improved in both markets, with Japan up 7.7% and U.S. up 16.9%, though management remains cautious about pandemic-related headwinds in 2022. Capital management remained a focus: Aflac repurchased $2.3 billion of stock in 2021 and retained 55.8 million shares of repurchase authorization, while the board set a first-quarter 2022 dividend of $0.40 per share, a 21.2% increase. For investors, the key takeaways are strong underlying profitability and shareholder returns, offset by declining premium volume, GAAP earnings pressure from investment and tax items, and continued sensitivity to the yen/dollar exchange rate and pandemic conditions in Japan and the U.S. Book value per share rose to $50.99 on a GAAP basis and $39.65 on an adjusted basis.

Feb 2, 20228-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Oct 27, 2021)

Aflac reported third quarter 2021 net earnings of $888 million, or $1.32 per diluted share, down sharply from $2.5 billion ($3.44 per share) a year earlier. The comparison is distorted by a $1.4 billion tax valuation allowance release in Q3 2020. Investors should focus on adjusted earnings, which rose 3.7% to $1.0 billion, or $1.53 per diluted share (up 10.1%). The drivers were lower-than-expected benefit ratios and higher net investment income, mainly in Japan, partly offset by a higher effective tax rate. Net investment losses of $172 million, mostly from a $119 million decline in equity securities fair value, weighed on GAAP results. Top-line and sales trends were mixed. Total revenues fell 7.6% to $5.2 billion. In Japan, yen-denominated premium income dropped 4.0% and new annualized premium sales were flat, constrained by face-to-face sales limits during pandemic conditions. Japan's pretax adjusted profit margin improved to 26.3% from 19.4%. In the U.S., sales rose 35.0% to $299 million on increased face-to-face activity, although net premium income declined 1.0%. Nine-month adjusted EPS grew 19.8% to $4.65, or 20.1% excluding currency effects. Capital position remained strong. Shareholders' equity was $33.6 billion ($50.62 per share), and adjusted book value was $39.06 per share, up 11.9%. Aflac repurchased $525 million of stock in the quarter, leaving 67.0 million shares authorized, and declared a $0.33 quarterly dividend, extending its streak of annual dividend increases to 39 consecutive years. Management described the outlook as dependent on the pace of pandemic recovery in Japan and small-business demand in the U.S.

Oct 27, 20218-K/A
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K/A Report, Financial Results (Jul 29, 2021)

Aflac reported second quarter 2021 net earnings of $1.1 billion, or $1.62 per diluted share, up 37.3% from $805 million a year earlier, driven mainly by $85 million of pretax adjusted net investment gains (versus losses of $166 million in Q2 2020). Adjusted earnings rose 17.3% to $1.08 billion, or $1.59 per diluted share (up 24.2%), reflecting lower-than-expected benefit ratios, higher net investment income in Japan, and a favorable tax rate. Total revenues grew 2.9% to $5.6 billion. Results were supported by $112 million of alternative investment returns above long-term expectations, so part of the strength may not recur at the same level. Segment trends were mixed. Aflac Japan's yen-denominated premium income fell 3.8%, but adjusted net investment income rose 27.4% and the pretax adjusted profit margin widened to 26.5% from 22.0%. Japan sales rose 38.4% in yen on a new medical product and improved pandemic conditions. Aflac U.S. premium income declined 3.4% on constrained sales, and pretax adjusted earnings fell 3.1%, though U.S. sales rose 64.1% from a low base. Management expects a stronger second half in both countries, while noting that small businesses are still recovering and that the Japan Post Group's resumption of proactive sales should help cancer insurance sales. Capital returns remained a priority. Aflac repurchased $500 million of stock (9.2 million shares) in the quarter, leaving 76.5 million shares authorized. Shareholders' equity reached $33.7 billion ($50.20 per share), and adjusted book value was $38.27 per share. The board declared a $0.33 quarterly dividend payable September 1, 2021, and management emphasized its 38-year record of dividend growth. This filing is an 8-K/A that only corrects a reference in the press release from "total adjusted revenues" to "total revenues" for the first half of 2021; the financial figures are unchanged.

Jul 29, 20218-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Jul 28, 2021)

Aflac reported Q2 2021 net earnings of $1.1 billion, or $1.62 per diluted share, up 37.3% from $805 million a year earlier, with total revenues rising 2.9% to $5.6 billion. The headline figure was flattered by pretax adjusted net investment gains of $85 million, driven mainly by a $170 million increase in equity security fair values. On an operating basis, adjusted earnings rose 17.3% to $1.08 billion, or $1.59 per diluted share (up 24.2%), reflecting lower-than-expected benefit ratios and higher net investment income, primarily in Japan. Management also flagged $112 million of alternative investment returns above long-term expectations in the quarter, so a portion of the earnings strength is non-recurring in nature. The Japan segment was the primary driver. Pretax adjusted earnings in dollar terms rose 19.7% to $1.0 billion, and the segment margin widened to 26.5% from 22.0%. Adjusted net investment income in yen increased 27.4%, while premium income declined 3.8% as limited-pay products reached paid-up status and pandemic-constrained sales weighed on volume. New Japan sales improved 38.4% in yen terms, aided by the new medical product launched in the first quarter. The U.S. business remained under pressure: net premium income fell 3.4%, pretax adjusted earnings declined 3.1%, and management described small businesses as still in recovery mode, with larger employers focused on returning staff to the worksite. U.S. sales did rebound 64.1% in the quarter, but from a depressed base. Capital management remained active. Aflac repurchased $500 million of stock (9.2 million shares) during the quarter, leaving 76.5 million shares authorized, and declared a third-quarter dividend of $0.33 per share, up 17.9% year over year, extending a 38-year record of dividend growth. Shareholders' equity reached $33.7 billion, or $50.20 per share, while adjusted book value excluding AOCI was $38.27 per share, up 20.5%. Investors should weigh the strong headline profitability against the reliance on investment gains and favorable benefit ratios tied to pandemic conditions, which may not persist.

Jul 28, 20218-K
Shareholder Matters

AFLAC INC 8-K Report, Shareholder Vote Results (May 6, 2021)

This 8-K filing from Aflac Incorporated (AFL) reports on the results of its Annual Meeting of Shareholders held on May 3, 2021. The primary focus is on the voting outcomes for key corporate governance and shareholder-approved matters. Notably, all proposals presented to shareholders, including the election of 11 directors, a non-binding advisory vote on executive compensation, and the ratification of KPMG LLP as the independent auditor for fiscal year 2021, received overwhelming approval. The strong shareholder support across all proposals indicates confidence in the current board of directors, management's compensation philosophy, and the company's independent audit oversight. The filing details the specific vote counts, abstentions, and broker non-votes for each proposal, demonstrating a high level of engagement and approval from the company's shareholders.

May 6, 20218-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Apr 28, 2021)

Aflac reported first quarter 2021 results on April 28, 2021, with reported net earnings of $1.3 billion ($1.87 per diluted share), up 128.4% from $566 million a year earlier. The headline figure was driven mainly by higher net investment gains, which are excluded from the company's adjusted earnings. Adjusted earnings rose 20.0% to $1.1 billion ($1.53 per diluted share, up 26.4%), supported by lower-than-expected benefit ratios in the U.S. and favorable tax rates. Management noted that pandemic-related low claims are flattering profitability, and that these conditions weighed on sales and earned premium. Top-line trends were weaker. Total revenues rose 13.7% to $5.9 billion on investment gains, but net premium income fell in both segments: Aflac Japan declined 0.9% in dollars (3.6% in yen) and Aflac U.S. declined 4.1%. New sales were essentially flat in Japan at ¥14.0 billion and fell 22.1% in the U.S. to $251 million. Management expects pandemic conditions to persist through the first half of 2021, with improvement in the second half as the U.S. and Japan reopen. Balance sheet and capital metrics were strong. Shareholders' equity reached $32.1 billion ($47.16 per share), and adjusted book value excluding AOCI was $37.16 per share. The company repurchased $650 million of stock in the quarter and declared a $0.33 quarterly dividend, a 17.9% increase year over year. Management also emphasized its 38-year record of dividend growth. Investors should weigh the strong earnings quality against the risk that benefit-ratio tailwinds reverse as claims normalize.

Apr 28, 20218-K
Other EventsExhibits & Filings

AFLAC INC 8-K Report, Corporate Update (Apr 15, 2021)

Aflac Incorporated (AFL) filed an 8-K on April 15, 2021, to report a significant debt issuance. The company successfully issued a total of ¥84,000,000,000 across five series of senior notes with varying maturities and coupon rates, ranging from 0.633% in 2031 to 1.560% in 2051. This offering was conducted through a public offering under the company's existing shelf registration. The primary purpose of this debt issuance is to fund the redemption of Aflac's outstanding 3.625% Senior Notes due 2023. Any proceeds exceeding the redemption amount will be utilized for general corporate purposes. This strategic move indicates Aflac's proactive management of its debt obligations, likely aiming to refinance at potentially lower interest rates given the rates on the newly issued notes compared to the notes being redeemed. The transaction was executed with several underwriters, including prominent firms like Goldman Sachs International, Mizuho Securities USA LLC, Morgan Stanley & Co. International plc, and SMBC Nikko Securities America, Inc.

Apr 15, 20218-K
Other EventsExhibits & Filings

AFLAC INC 8-K Report, Corporate Update (Mar 8, 2021)

Aflac Incorporated announced on March 8, 2021, the successful issuance of $400 million in 1.125% Senior Sustainability Notes due 2026. This offering, conducted under a public registration statement, highlights Aflac's commitment to environmental and social initiatives, as the net proceeds are earmarked for eligible sustainability-focused investments and projects. The notes bear a relatively low interest rate of 1.125% and mature in 2026, with interest payments semi-annually. The company retains the option to redeem the notes prior to maturity under specific conditions, with redemption prices varying based on proximity to the maturity date. As general unsecured senior obligations, these notes rank equally with other existing and future unsecured senior indebtedness of Aflac.

Mar 8, 20218-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Feb 3, 2021)

Aflac reported fourth-quarter 2020 net earnings of $951 million, or $1.35 per diluted share, up from $782 million ($1.06) a year earlier. The increase was driven mainly by $268 million of pretax net investment gains, largely from a $290 million mark-up on equity securities tied to its Trupanion investment. Excluding those gains, which the company reports separately from adjusted earnings, adjusted earnings were essentially flat at $755 million, and adjusted EPS rose 3.9% to $1.07. Results were held back by a $43 million voluntary separation plan expense, which the company treats as a one-time cost, and by pandemic-related weakness in sales and earned premium. Full-year 2020 net earnings were $4.8 billion, or $6.67 per diluted share, but this figure was inflated by a $1.41 billion tax valuation allowance release tied to foreign tax credits. Adjusted earnings for the year were $3.6 billion, or $4.96 per diluted share, up 11.7% (10.8% excluding a $0.04 currency benefit). Total revenues fell 0.7% to $22.1 billion. Sales were the main weak spot: Aflac Japan new annualized premium sales fell 36.2% for the year and Aflac U.S. sales fell 30.8%, both attributed to pandemic constraints on face-to-face selling. Management expects these conditions to persist through the first half of 2021. Capital return remained a focus. The company repurchased $1.5 billion of stock in 2020, leaving 99.2 million shares authorized, and reaffirmed a 17.9% increase in the first-quarter dividend to $0.33 per share, extending its 38-year streak of dividend increases. Shareholders' equity reached $33.6 billion, or $48.46 per share, and adjusted book value per share (excluding AOCI) was $35.56. Investors should weigh the strong headline earnings against the underlying softness in sales and the one-time nature of several 2020 items.

Feb 3, 20218-K
Regulation FD

AFLAC INC 8-K Report, Regulation FD Disclosure (Nov 18, 2020)

Aflac Incorporated (AFL) announced its upcoming Financial Analyst Briefing, scheduled for November 19, 2020. Management will use this forum to discuss key aspects of the company's operations in both Japan and the United States, providing insights into their capital management strategies and financial outlook. A significant focus will be placed on how the ongoing COVID-19 pandemic is impacting the business and the company's forward-looking strategies to navigate these challenges. Investors should note that the presentation slides for this briefing have been made available on Aflac's investor relations website. While this 8-K filing primarily serves to announce the event and provides the standard forward-looking statement disclosures, it signals an important opportunity for investors to gain a deeper understanding of Aflac's strategic direction and financial health in a dynamic economic environment.

Nov 18, 20208-K
Earnings & ResultsExhibits & Filings

AFLAC INC 8-K Report, Financial Results (Oct 27, 2020)

Aflac's third quarter 2020 results were dominated by a one-time non-cash tax benefit. Net earnings were $2.5 billion, or $3.44 per diluted share, versus $777 million ($1.04) a year ago, driven by a $1.4 billion benefit from releasing valuation allowances on deferred foreign tax credits after the September 29, 2020 U.S. Treasury/IRS regulations. Excluding this and investment gains, the underlying picture is more mixed. Adjusted earnings rose 15.2% to $994 million, and adjusted EPS grew 19.8% to $1.39, largely from a lower effective tax rate. Total revenues rose 2.3% to $5.7 billion in the quarter but fell 2.8% year to date to $16.2 billion, reflecting pandemic-driven sales declines. The operating story is weaker. Sales fell sharply in both segments: Aflac Japan's total sales dropped 32.0% in the quarter (about 40% year to date) and Aflac U.S. sales fell 35.7%. Japan's pretax adjusted profit margin compressed to 19.4% from 21.4%, and U.S. net premium income declined 2.6%. Management expects COVID-19 to significantly weigh on full-year sales in both countries. It is also taking cost actions, including a voluntary separation plan reducing the U.S. insurance and corporate workforce by about 9%, with $45–50 million of run-rate annual savings against roughly $45 million of fourth-quarter one-time expense. Management described these as short-term headwinds to margins. Capital position remained solid. Shareholders' equity reached $32.5 billion ($46.16 per share), though adjusted book value excluding AOCI was $24.6 billion ($34.91 per share), up about 15.7% year over year. Aflac repurchased $400 million of stock in the quarter, leaving 110.9 million shares authorized, and declared a $0.28 quarterly dividend, marking the 38th consecutive year of dividend increases. Investors should view the headline EPS as inflated by the tax benefit, and focus on the sales declines and margin pressure in the coming quarters.

Oct 27, 2020
Page 1 of 6